The aim of the British Society for Gene and Cell Therapy is to accelerate scientific progress and promote ethical and efficient transfer of gene- and cell-based technologies from the laboratory into the clinic.

Gene and cell therapy is an area where co-operation between ALL the interested parties – general public, patients, scientists, government and the media – is vital for the optimal development of these technologies and treatments, and BSGCT is working towards becoming this pro-active interface.